Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Japanese Investors Co-lead Biotech Firm Promethera's $44M Series D
Venture Capital

Japanese Investors Co-lead Biotech Firm Promethera's $44M Series D

by dealstreetasia.com posted 2weeks ago 25 views
Investors that joined the round include Japan’s Medipal Holdings Corporation and Ci:z Investment, Mirae Asset Capital and Korea Investment Partners. The post Japanese investors co-lead European biotech firm Promethera’s $44m Series D appeared first on DealStreetAsia.

In this article